UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus

NCT06920433 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: UCAR T-cell group

Sponsor

Zhejiang University

Collaborators

[object Object]